MUSTANG BIO, INC. Stock-Based Compensation
MUSTANG BIO, INC. (MBIO) reported Stock-Based Compensation of $21.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- MUSTANG BIO, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $21.00K, a 53.33% decline year-over-year.
- MUSTANG BIO, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $22.00K, a 42.11% decline year-over-year.
- MUSTANG BIO, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $23.00K, a 54.00% decline year-over-year.
- MUSTANG BIO, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $23.00K, a 45.24% decline year-over-year.
- MUSTANG BIO, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $129.00K.
- MUSTANG BIO, INC. share-based payment arrangement, noncash expense for fiscal 2024 was -$450.00K, a 179.23% decline from fiscal 2023.
- MUSTANG BIO, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $568.00K, a 75.12% decline from fiscal 2022.
- MUSTANG BIO, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $2.28M, a 30.99% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 10 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $21.00K 10-Q · filed 2026-08-05 | $43.00K 10-Q · filed 2026-08-05 | $66.00K derived: sum of 3 quarters · filed 2026-08-05 | $89.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $22.00K 10-Q · filed 2026-05-05 | $45.00K derived: sum of 2 quarters · filed 2026-05-05 | $68.00K derived: sum of 3 quarters · filed 2026-05-05 | $113.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $46.00K derived: sum of 2 quarters · filed 2026-03-19 | $91.00K derived: sum of 3 quarters · filed 2026-08-05 | $129.00K 10-K · filed 2026-03-19 | |
| 2025-09-30 | $23.00K 10-Q · filed 2025-11-07 | $68.00K derived: sum of 2 quarters · filed 2026-08-05 | $106.00K 10-Q · filed 2025-11-07 | $156.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $45.00K 10-Q · filed 2026-08-05 | $83.00K 10-Q · filed 2026-08-05 | $133.00K derived: sum of 3 quarters · filed 2026-08-05 | $175.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $38.00K 10-Q · filed 2026-05-05 | $88.00K derived: sum of 2 quarters · filed 2026-05-05 | $130.00K derived: sum of 3 quarters · filed 2026-05-05 | -$489.00K derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $92.00K derived: sum of 2 quarters · filed 2026-03-19 | -$527.00K derived: sum of 3 quarters · filed 2026-03-19 | -$450.00K 10-K · filed 2026-03-19 | |
| 2024-09-30 | $42.00K 10-Q · filed 2025-11-07 | -$577.00K derived: sum of 2 quarters · filed 2025-11-07 | -$500.00K 10-Q · filed 2025-11-07 | -$313.00K derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | -$619.00K 10-Q · filed 2025-08-08 | -$542.00K 10-Q · filed 2025-08-08 | -$355.00K derived: sum of 3 quarters · filed 2025-08-08 | -$255.00K derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | $76.00K 10-Q · filed 2025-05-14 | $264.00K derived: sum of 2 quarters · filed 2025-05-14 | $364.00K derived: sum of 3 quarters · filed 2025-05-14 | $409.00K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $288.00K derived: sum of 2 quarters · filed 2025-03-28 | $333.00K derived: sum of 3 quarters · filed 2025-03-28 | $568.00K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-08 | $145.00K derived: sum of 2 quarters · filed 2024-11-08 | $380.00K 10-Q · filed 2024-11-08 | $853.00K derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | $45.00K 10-Q · filed 2024-08-13 | $280.00K 10-Q · filed 2024-08-13 | $753.00K derived: sum of 3 quarters · filed 2024-08-13 | $1.25M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $235.00K 10-Q · filed 2024-05-15 | $708.00K derived: sum of 2 quarters · filed 2024-05-15 | $1.20M derived: sum of 3 quarters · filed 2024-05-15 | $1.85M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $473.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $969.00K derived: sum of 2 quarters · filed 2024-03-11 | $1.62M derived: sum of 3 quarters · filed 2024-03-11 | $2.28M 10-K · filed 2024-03-11 | |
| 2022-09-30 | $496.00K 10-Q · filed 2023-11-14 | $1.15M derived: sum of 2 quarters · filed 2023-11-14 | $1.81M 10-Q · filed 2023-11-14 | $2.69M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $650.00K 10-Q · filed 2023-08-14 | $1.31M 10-Q · filed 2023-08-14 | $2.19M derived: sum of 3 quarters · filed 2023-08-14 | $3.08M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $664.00K 10-Q · filed 2023-05-12 | $1.54M derived: sum of 2 quarters · filed 2023-05-12 | $2.43M derived: sum of 3 quarters · filed 2023-05-12 | $2.98M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $881.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.76M derived: sum of 2 quarters · filed 2023-03-30 | $2.31M derived: sum of 3 quarters · filed 2023-03-30 | $3.31M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $884.00K 10-Q · filed 2022-11-14 | $1.43M derived: sum of 2 quarters · filed 2022-11-14 | $2.43M 10-Q · filed 2022-11-14 | $3.05M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $547.00K 10-Q · filed 2022-08-11 | $1.54M 10-Q · filed 2022-08-11 | $2.16M derived: sum of 3 quarters · filed 2022-08-11 | $2.77M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $996.00K 10-Q · filed 2022-05-12 | $1.61M derived: sum of 2 quarters · filed 2022-05-12 | $2.22M derived: sum of 3 quarters · filed 2022-05-12 | $3.18M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $619.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $1.23M derived: sum of 2 quarters · filed 2022-03-23 | $2.18M derived: sum of 3 quarters · filed 2022-03-23 | $2.99M 10-K · filed 2022-03-23 | |
| 2020-09-30 | $606.00K 10-Q · filed 2021-11-12 | $1.56M derived: sum of 2 quarters · filed 2021-11-12 | $2.37M 10-Q · filed 2021-11-12 | $2.86M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | $957.00K 10-Q · filed 2021-08-16 | $1.76M 10-Q · filed 2021-08-16 | $2.25M derived: sum of 3 quarters · filed 2021-08-16 | $3.37M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $805.00K 10-Q · filed 2021-05-14 | $1.29M derived: sum of 2 quarters · filed 2021-05-14 | $2.42M derived: sum of 3 quarters · filed 2021-05-14 | $3.04M derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | $490.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $1.61M derived: sum of 2 quarters · filed 2021-03-24 | $2.23M derived: sum of 3 quarters · filed 2021-03-24 | $2.66M 10-K · filed 2021-03-24 | |
| 2019-09-30 | $1.12M 10-Q · filed 2020-11-06 | $1.74M derived: sum of 2 quarters · filed 2020-11-06 | $2.17M 10-Q · filed 2020-11-06 | $3.27M derived: sum of 4 quarters · filed 2020-11-06 | |
| 2019-06-30 | $622.00K 10-Q · filed 2020-08-10 | $1.05M 10-Q · filed 2020-08-10 | $2.15M derived: sum of 3 quarters · filed 2020-08-10 | $3.05M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $432.00K 10-Q · filed 2020-05-11 | $1.52M derived: sum of 2 quarters · filed 2020-05-11 | $2.43M derived: sum of 3 quarters · filed 2020-05-11 | $3.40M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $1.99M derived: sum of 2 quarters · filed 2020-03-16 | $2.96M derived: sum of 3 quarters · filed 2020-03-16 | $4.96M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $903.00K 10-Q · filed 2019-11-12 | $1.87M derived: sum of 2 quarters · filed 2019-11-12 | $3.87M 10-Q · filed 2019-11-12 | $4.65M derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | $971.00K 10-Q · filed 2019-08-09 | $2.97M 10-Q · filed 2019-08-09 | $3.75M derived: sum of 3 quarters · filed 2019-08-09 | $4.58M derived: sum of 4 quarters · filed 2019-08-09 | |
| 2018-03-31 | $2.00M 10-Q · filed 2019-05-10 | $2.78M derived: sum of 2 quarters · filed 2019-05-10 | $3.61M derived: sum of 3 quarters · filed 2019-05-10 | $4.01M derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | $782.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $1.62M derived: sum of 2 quarters · filed 2019-03-18 | $2.01M derived: sum of 3 quarters · filed 2019-03-18 | $2.01M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $834.00K 10-Q · filed 2018-11-13 | $1.23M derived: sum of 2 quarters · filed 2018-11-13 | $1.23M 10-Q · filed 2018-11-13 | $1.23M derived: sum of 4 quarters · filed 2018-11-13 | |
| 2017-06-30 | $397.00K 10-Q · filed 2018-08-13 | $397.00K 10-Q · filed 2018-08-13 | $397.00K derived: sum of 3 quarters · filed 2018-08-13 | $397.00K derived: sum of 4 quarters · filed 2018-08-13 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-14 | $0.00 derived: sum of 2 quarters · filed 2018-05-14 | $0.00 derived: sum of 3 quarters · filed 2018-05-14 | $0.00 derived: sum of 4 quarters · filed 2018-05-14 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $0.00 derived: sum of 2 quarters · filed 2018-03-29 | $0.00 derived: sum of 3 quarters · filed 2018-03-29 | $0.00 10-K · filed 2018-03-29 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |